| [1] |
Duffy JP, Eibl G, Reber HA, et al. Influence of hypoxia and neoangiogenesis on the growth of pancreatic cancer. Mol Cancer,2003, 22(1):2-12.
|
| [2] |
Varlotto J, Stevenson MA. Anemia, tumor hypoxemia, and the cancer patient. Int J Radiat Oneol Biol Phys, 2005, 63(1):25-36.
|
| [3] |
Shibata T, Giaccia A J, Brown JM. Development of a hypoxiaresponsive vector for tumor-specific gene therapy. Gene Ther, 2000, 7(6):493-498.
|
| [4] |
Shi Y, Zhai H, Fan D, et al. Ribosomal proteins S13 and L23 promote multidrug resistance in gastric cancer cells by suppressing drug-induced apoptosis. Exp Cell Res, 2004, 296(2):337-346.
|
| [5] |
Smythe WR. Prodrug/drug sensitivity gene therapy:current status.Curr Oncol Rep, 2000, 2(1):17-22.
|
| [6] |
Liu J, Zou WG, Liu XY, et al. Cancer-specific killing by the CD suicide gene using the human telomerase reverse transcriptase promoter. Int J Oncol, 2002, 21(3):661-666.
|
| [7] |
Zhang SN. Yuan SZ, Zeng ZY, et al. Apoptosis induced by 5-flucytosine in human pancreatic cancer cells genetically modified to express cytosine deaminase. Acta Pharmacol Sin, 2000, 21(7):655-659.
|
| [8] |
Pan X, Li ZS, Tu ZX, et al. Adenovirus-mediated gene transfer in the treatment of pancreatic cancer. Pancreas, 2003, 26(3):274-278.
|
| [9] |
Chadderton N, Cowen RL, Williams KJ, et al. Dual responsive promoters to target therapeutic gene expression to radiation-resistant hypoxic tumor cells. Int J Radiat Oncol Biol Phys, 2005,62(1):213-222.
|
| [10] |
Huang D, Desbois A, Hou ST. A novel adenoviral vector which mediates hypoxia-inducible gene expression selectively in neurons.Gene Ther, 2005, 12(18):1369-1376.
|
| [11] |
Belozerov VE, Van Meir EG. Hypoxia inducible factor-1:a novel target for cancer therapy. Anticancer Drugs, 2005, 16(9):901-909.
|
| [12] |
Harrison L, BlackweU K. Hypoxia and anemia:factors in decreased sensitivity to radiation therapy and chemotherapy?. Oncologist.,2004, 9(Suppl 5):31-40.
|